These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 16652281)

  • 21. Persistence of protection to hepatitis B vaccine and response to booster dose among children and adolescents in Dakahleya- Egypt.
    Salama II; Sami SM; Salama SI; Foud WA; Abdel Hamid AT; Said ZN
    Egypt J Immunol; 2014; 21(1):13-26. PubMed ID: 25204041
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Further observations on the immune response to recombinant hepatitis B vaccine after administration to aboriginal and Torres Strait Island children.
    Hanna JN; Faoagali JL; Buda PJ; Sheridan JW
    J Paediatr Child Health; 1997 Feb; 33(1):67-70. PubMed ID: 9069048
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Serum Anti-HBs Level Among Children Who Received Routine Hepatitis B Vaccination During Infancy in Mianyang City, China: A Cross-Sectional Study.
    He F; Ma YJ; Zhou TY; Duan JC; Wang JF; Ji YL; Li H; Zhang JY; Tang H
    Viral Immunol; 2016; 29(1):40-8. PubMed ID: 26565951
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Early and long term anamnestic response to HBV booster dose among fully vaccinated Egyptian children during infancy.
    Salama II; Sami SM; Said ZN; Salama SI; Rabah TM; Abdel-Latif GA; Elmosalami DM; Saleh RM; Abdel Mohsin AM; Metwally AM; Hassanin AI; Emam HM; Hemida SA; Elserougy SM; Shaaban FA; Fouad WA; Mohsen A; El-Sayed MH
    Vaccine; 2018 Apr; 36(15):2005-2011. PubMed ID: 29530634
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunogenicity of compulsory and booster doses of hepatitis B vaccine among children in Cairo, Egypt.
    Salama I; Sami S; Saleh R; Mohsen A; Elserougy S; Emam H; Said Z
    J Egypt Public Health Assoc; 2017 Jun; 92(2):77-85. PubMed ID: 30184404
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Long-term efficacy of plasma-derived hepatitis B vaccine among Chinese children--a 12-year follow-up].
    Liao S; Li R; Li H; Yang J; Zeng X
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1998 Apr; 20(2):89-94. PubMed ID: 11367725
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long-term antibody persistence against hepatitis B in adolescents 14-15-years of age vaccinated with 4 doses of hexavalent DTPa-HBV-IPV/Hib vaccine in infancy.
    Schwarz TF; Behre U; Adelt T; Donner M; Suryakiran PV; Janssens W; Mesaros N; Panzer F
    Hum Vaccin Immunother; 2019; 15(1):235-241. PubMed ID: 30118633
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A 9-year follow-up study of the immunogenicity and long-term efficacy of plasma-derived hepatitis B vaccine in high-risk Chinese neonates.
    Ding L; Zhang M; Wang Y; Zhou S; Kong W; Smego RA
    Clin Infect Dis; 1993 Sep; 17(3):475-9. PubMed ID: 8218692
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hepatitis B vaccination in children: the Taiwan experience.
    Ni YH; Chen DS
    Pathol Biol (Paris); 2010 Aug; 58(4):296-300. PubMed ID: 20116181
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Significance and anamnestic response in isolated hepatitis B core antibody-positive individuals 18 years after neonatal hepatitis B virus vaccination in Taiwan.
    Su FH; Bai CH; Chu FY; Lin YS; Su CT; Yeh CC
    Vaccine; 2012 Jun; 30(27):4034-9. PubMed ID: 22531558
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Persistence of protection against hepatitis B virus infection among adolescents vaccinated with recombinant hepatitis B vaccine beginning at birth: a 15-year follow-up study.
    Bialek SR; Bower WA; Novak R; Helgenberger L; Auerbach SB; Williams IT; Bell BP
    Pediatr Infect Dis J; 2008 Oct; 27(10):881-5. PubMed ID: 18756185
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long-term persistence in protection and response to a hepatitis B vaccine booster among adolescents immunized in infancy in the western region of China.
    Wang ZZ; Gao YH; Lu W; Jin CD; Zeng Y; Yan L; Ding F; Li T; Liu XE; Zhuang H
    Hum Vaccin Immunother; 2017 Apr; 13(4):909-915. PubMed ID: 27874311
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Respective importance of vertical and horizontal transmission of hepatitis B in the Australian archipelago (French Polynesia). Preliminary results of the vaccination of newborns].
    Boutin JP; Spiegel A; Flye Sainte-Marie F; Cartel JL; Girard M; Saliou P; Roux J
    Bull Soc Pathol Exot; 1991; 84(5 Pt 5):906-11. PubMed ID: 1840244
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serological and molecular epidemiological outcomes after two decades of universal infant hepatitis B virus (HBV) vaccination in Nunavut, Canada.
    Huynh C; Minuk GY; Uhanova J; Baikie M; Wong T; Osiowy C
    Vaccine; 2017 Aug; 35(35 Pt B):4515-4522. PubMed ID: 28736196
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antibody titration and immune response of Iranian beta-thalassemic patients to hepatitis B virus vaccine (booster effect).
    Azarkeivan A; Karimi G; Shaiegan M; Maghsudlu M; Tabbaroki A
    Pediatr Hematol Oncol; 2009 Jun; 26(4):195-201. PubMed ID: 19437322
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Hepatocellular carcinoma: a preventable cancer].
    Viviani S; Jack A; Bah E; Montesano R
    Epidemiol Prev; 1997; 21(2):129-36. PubMed ID: 9378180
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antibody levels and protection after hepatitis B vaccination: results of a 15-year follow-up.
    McMahon BJ; Bruden DL; Petersen KM; Bulkow LR; Parkinson AJ; Nainan O; Khristova M; Zanis C; Peters H; Margolis HS
    Ann Intern Med; 2005 Mar; 142(5):333-41. PubMed ID: 15738452
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hepatitis B immune status in adolescents vaccinated during infancy: A retrospective cohort study from a pediatric practice in Germany.
    Anderson CL; Remschmidt C; Drobnitzky FP; Falkenhorst G; Zimmermann R; Wichmann O; Harder T
    Hum Vaccin Immunother; 2016 Mar; 12(3):779-84. PubMed ID: 26633195
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Long-term efficacy of vaccination against hepatitis B in newborns: 13 years' follow-up].
    Wu W; Sun C; Jiang M; Xu Y; Zhang GH; Liu CB; Cao HL; Lin XM; Xu ZY
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2001 Sep; 15(3):239-41. PubMed ID: 11986695
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Post-vaccination serologic testing of infants born to hepatitis B surface antigen positive mothers in 4 provinces of China.
    Wang F; Zhang G; Zheng H; Miao N; Shen L; Wang F; Dong P; Du F; Chen C; Zhang X; Cui F
    Vaccine; 2017 Jul; 35(33):4229-4235. PubMed ID: 28651839
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.